Literature DB >> 7619328

Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients.

A Baglin1, J C Boulard, T Hanslik, J Prinseau.   

Abstract

There is a wide variety of diuretic-induced metabolic abnormalities of unequal severity. Renal failure can be caused by excessive sodium loss, or by certain drug combinations comprising, for instance, a nonsteroidal anti-inflammatory drug (NSAID) or an ACE inhibitor. Hyponatraemia is uncommon. It is encountered with thiazides, especially among women. A sodium level less than 120 mmol/L may result in neurological complications. Hypokalaemia is frequent and might increase the risk of cardiac arrhythmia. Hyperkalaemia induced by potassium-sparing diuretics is often combined with another contributive cause. Glucidic, lipidic and uric acid abnormalities are common, but their clinical effects are slight. They do not seem to worsen cardiovascular risks among elderly patients. Nevertheless, prescribing diuretics for elderly patients requires special precautions. Reducing the diuretic dose, as is now recommended for treating hypertension, seems to lessen adverse effects, and despite all the adverse reactions just mentioned, it has been proven that diuretics are beneficial in many diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619328     DOI: 10.2165/00002018-199512030-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  48 in total

Review 1.  Diuretic-induced hypokalemia.

Authors:  R L Tannen
Journal:  Kidney Int       Date:  1985-12       Impact factor: 10.612

Review 2.  Drug-induced hyperkalemia.

Authors:  S P Ponce; A E Jennings; N E Madias; J T Harrington
Journal:  Medicine (Baltimore)       Date:  1985-11       Impact factor: 1.889

3.  beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects.

Authors:  G Berglund; O Andersson
Journal:  Lancet       Date:  1981-04-04       Impact factor: 79.321

4.  Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis.

Authors:  J C Ayus; R K Krothapalli; A I Arieff
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

5.  Diuretic therapy for hypertension and the risk of primary cardiac arrest.

Authors:  D S Siscovick; T E Raghunathan; B M Psaty; T D Koepsell; K G Wicklund; X Lin; L Cobb; P M Rautaharju; M K Copass; E H Wagner
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

6.  changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.

Authors:  A S Brickman; S G Massry; J W Coburn
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

7.  Elevation of serum lipid levels during diuretic therapy of hypertension.

Authors:  R P Ames; P Hill
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

8.  [Electrolyte abnormalities in elderly people. Prevalence and relation to drug treatment. Multicenter study of 631 subjects aged 70 years and over].

Authors:  A Baglin; J Prinseau; P Aegerter; A M Piette; P Mornet; M Goupil; G Lesur; J P Gayno; F Bournerias; J M Rémy
Journal:  Presse Med       Date:  1992-09-26       Impact factor: 1.228

9.  The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives.

Authors:  D K Falch; A Schreiner
Journal:  Acta Med Scand       Date:  1983

10.  Osmotic demyelination syndrome following correction of hyponatremia.

Authors:  R H Sterns; J E Riggs; S S Schochet
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

View more
  6 in total

1.  Hyponatremic encephalopathy induced by thiazides.

Authors:  J Al-Salman; R Pursell
Journal:  West J Med       Date:  2001-08

Review 2.  Best practice in primary care pathology: review 6.

Authors:  W S A Smellie; J Forth; J J Coleman; W Irvine; P C Dore; G Handley; D G Williams; P J Galloway; K G Kerr; R Herriot; G P Spickett; T M Reynolds
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

Review 3.  Cardiovascular drug therapy in the elderly: benefits and challenges.

Authors:  Jerome L Fleg; Wilbert S Aronow; William H Frishman
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 4.  Treating hypertension in older adults: safety considerations.

Authors:  Wilbert S Aronow
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Antihypertensive treatment in elderly patients aged 75 years or over: a 24-week study of the tolerability of candesartan cilexetil in relation to hydrochlorothiazide.

Authors:  S Neldam; B Forsén
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

6.  Diuretic drug therapy monitoring in the elderly: a cohort study.

Authors:  Marie Gérardin-Marais; Caroline Victorri-Vigneau; Gwenaëlle Allain-Veyrac; Anicet Chaslerie; Maryse Nicolas; Nathalie Sarraf; Jacques Pivette; Pascale Jolliet
Journal:  Eur J Clin Pharmacol       Date:  2008-01-05       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.